Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Fei Qi, Bo Chen, Jingjing Wang, Xinyi Lin, Shunan Qi, Jianliang Yang, Shengyu Zhou, Shulian Wang, Lin Gui, Hui Fang, Peng Liu, Yongwen Song, Sheng Yang, Yexiong Li & Mei Dong. (2019) Upfront radiation is essential for high-risk early-stage extranodal NK/T-cell lymphoma, nasal type: comparison of two sequential treatment modalities combining radiotherapy and GDP (gemcitabine, dexamethasone, and cisplatin) in the modern era. Leukemia & Lymphoma 60:11, pages 2679-2688.
Read now
Read now
Qin Tong, Shuming Ouyang, Lingling Feng, Hanyu Wang, Yunfei Xia & Yujing Zhang. (2018) Salvage radiotherapy improves survival in patients with locoregionally relapsed stage IE–IIE extranodal natural killer/T-cell lymphoma, nasal type. Therapeutics and Clinical Risk Management 14, pages 1083-1090.
Read now
Read now
Articles from other publishers (14)
Xinhua Wang, Ken H. Young & Mingzhi Zhang. (2023) Should DDGP Regimen Be the Standard of Care for Advanced Extranodal NK/T-Cell Lymphoma? The New Staging System Matters—Reply. JAMA Oncology 9:2, pages 279.
Crossref
Crossref
Luo Huang, Yongzhong Wu, Ying Wang, Yue Xie, Furong Wu, Shujie Li, Zhongguo Liang & Xiaodong Zhu. (2020) Prognostic Nomogram for Overall Survival in Early Stage Extranodal Natural Killer/T Cell Lymphoma Treated With High-Dose Radiotherapy. Clinical Lymphoma Myeloma and Leukemia 20:5, pages 289-295.
Crossref
Crossref
Gangjian Wang, Yu Chang, Xiaolong Wu, Xin Li, Ling Li & Mingzhi Zhang. (2019) Prognostic nomogram for overall survival in upper aerodigestive tract extranodal natural killer/T‑cell lymphoma, nasal type, stages IE and IIE: A SEER‑based study. Oncology Letters.
Crossref
Crossref
Shu Tian, Ruichen Li, Tian Wang, Shengzi Wang, Rong Tao, Xichun Hu & Hao Ding. (2019) Gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy with sandwiched radiotherapy in the treatment of newly diagnosed stage IE/IIE extranodal natural killer/T‐cell lymphoma, nasal type. Cancer Medicine 8:7, pages 3349-3358.
Crossref
Crossref
Xin Liu, Tao Wu, Su-Yu Zhu, Mei Shi, Hang Su, Ying Wang, Xia He, Li-Ming Xu, Zhi-Yong Yuan, Li-Ling Zhang, Gang Wu, Bao-Lin Qu, Li-Ting Qian, Xiao-Rong Hou, Fu-Quan Zhang, Yu-Jing Zhang, Yuan Zhu, Jian-Zhong Cao, Sheng-Min Lan, Jun-Xin Wu, Shu-Nan Qi, Yong Yang & Ye-Xiong Li. (2019) Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma. JAMA Network Open 2:3, pages e190194.
Crossref
Crossref
Fei Qi, Wei-Hu Wang, Xiao-Hui He, Bo Chen, Lin Gui, Hui Fang, Peng Liu, Shu-Lian Wang, Jian-Liang Yang, Yong-Wen Song, Sheng Yang, Shu-Nan Qi, Sheng-Yu Zhou, Ye-Xiong Li & Mei Dong. (2018) Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study. International Journal of Radiation Oncology*Biology*Physics 102:1, pages 61-70.
Crossref
Crossref
VineetG Gupta, Ajay Gogia, Lalit Kumar, Atul Sharma, Sameer Bakhshi, MeharC Sharma, Saumyaranjan Mallick, Ahitagni Biswas, Prashant Mehta, Sanjay Thulkar, RanjitK Sahoo & Rakesh Kumar. (2018) Combined modality treatment with “dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide” chemotherapy and involved field radiotherapy for early stage natural Killer/T cell lymphoma with local tumor invasiveness: A single-institution study from India. Indian Journal of Medical and Paediatric Oncology 39:1, pages 67.
Crossref
Crossref
Run-Ye Wu, Kang Liu, Wei-Hu Wang, Jing Jin, Yong-Wen Song, Shu-Lian Wang, Yue-Ping Liu, Hua Ren, Hui Fang, Qing-Feng Liu, Yong Yang, Bo Chen, Shu-Nan Qi, Ning-Ning Lu, Yu Tang, Yuan Tang, Ning Li, Han Ouyang & Ye-Xiong Li. (2017) Patterns of Primary Tumor Invasion and Regional Lymph Node Spread Based on Magnetic Resonance Imaging in Early-Stage Nasal NK/T-cell Lymphoma: Implications for Clinical Target Volume Definition and Prognostic Significance. International Journal of Radiation Oncology*Biology*Physics 97:1, pages 50-59.
Crossref
Crossref
Yexiong Li. 2017. Radiation Therapy in Hematologic Malignancies. Radiation Therapy in Hematologic Malignancies
157
180
.
Rong Liang, Zhe Wang, Qing-Xian Bai, Guang-Xun Gao, Lan Yang, Tao Zhang, Hong-Tao Gu, Bao-Xia Dong, Mi-Mi Shu, Cai-Xia Hao, Na Zhang & Xie-Qun Chen. (2016) Natural Killer/T Cell Lymphoma, Nasal Type: A Retrospective Clinical Analysis in North-Western China. Oncology Research and Treatment 39:1-2, pages 45-52.
Crossref
Crossref
Yong YangYuan ZhuJian-Zhong CaoYu-Jing ZhangLi-Ming XuZhi-Yong YuanJun-Xin WuWei WangTao WuBing LuSu-Yu ZhuLi-Ting Qian, Fu-Quan Zhang, Xiao-Rong Hou & Ye-Xiong Li. (2015) Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study. Blood 126:12, pages 1424-1432.
Crossref
Crossref
Y Yang, Y-J Zhang, Y Zhu, J-Z Cao, Z-Y Yuan, L-M Xu, J-X Wu, W Wang, T Wu, B Lu, S-Y Zhu, L-T Qian, F-Q Zhang, X-R Hou, Q-F Liu & Y-X Li. (2015) Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study. Leukemia 29:7, pages 1571-1577.
Crossref
Crossref
Li Liang, Zhang Zhang, Ying Wang, Lin Nong, Yalin Zheng, Linlin Qu, Bo Zhang & Ting Li. (2015)
The Genetic Deletion of 6q21 and
PRDM1
and Clinical Implications in Extranodal NK/T Cell Lymphoma, Nasal Type
. BioMed Research International 2015, pages 1-12.
Crossref
Crossref
Aaron Auerbach & Nadine S. Aguilera. (2015) Epstein–Barr virus (EBV)-associated lymphoid lesions of the head and neck. Seminars in Diagnostic Pathology 32:1, pages 12-22.
Crossref
Crossref